skip to main content
Idioma:
Refinado por: tipo de recurso: Newsletter Articles remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
New Remdesivir Study Findings Have Been Reported by Investigators at OyaGeneral Inc. (P Sangivamycin Is Highly Effective Against Sars-cov-2 In Vitro and Has Favorable Drug Properties)
New Remdesivir Study Findings Have Been Reported by Investigators at OyaGeneral Inc. (P Sangivamycin Is Highly Effective Against Sars-cov-2 In Vitro and Has Favorable Drug Properties)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

New Remdesivir Study Findings Have Been Reported by Investigators at OyaGeneral Inc. (P Sangivamycin Is Highly Effective Against Sars-cov-2 In Vitro and Has Favorable Drug Properties)

Drug Week, 2022, p.1051

NewsRX LLC

Texto completo disponível

Citações Citado por
2
Study Data from OyaGeneral Inc. Provide New Insights into Remdesivir (Sangivamycin Is Highly Effective Against Sars-cov-2 In Vitro and Has Favorable Drug Properties)
Study Data from OyaGeneral Inc. Provide New Insights into Remdesivir (Sangivamycin Is Highly Effective Against Sars-cov-2 In Vitro and Has Favorable Drug Properties)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Study Data from OyaGeneral Inc. Provide New Insights into Remdesivir (Sangivamycin Is Highly Effective Against Sars-cov-2 In Vitro and Has Favorable Drug Properties)

Respiratory Therapeutics Week, 2022, p.1646

NewsRX LLC

Texto completo disponível

Citações Citado por
3
Researchers from National Institute of Allergy and Infectious Diseases
Researchers from National Institute of Allergy and Infectious Diseases
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Researchers from National Institute of Allergy and Infectious Diseases

World Disease Weekly, 2021, p.67

NewsRX LLC

Texto completo disponível

Citações Citado por
4
Researchers from National Institute of Allergy and Infectious Diseases Provide Details of New Studies and Findings in the Area of Ebola Virus (An Immunotoxin Targeting Ebola Virus Glycoprotein Inhibits Ebola Virus Production From ...)
Researchers from National Institute of Allergy and Infectious Diseases Provide Details of New Studies and Findings in the Area of Ebola Virus (An Immunotoxin Targeting Ebola Virus Glycoprotein Inhibits Ebola Virus Production From ...)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Researchers from National Institute of Allergy and Infectious Diseases Provide Details of New Studies and Findings in the Area of Ebola Virus (An Immunotoxin Targeting Ebola Virus Glycoprotein Inhibits Ebola Virus Production From ...)

World Disease Weekly, 2021, p.67

NewsRX LLC

Texto completo disponível

Citações Citado por
5
Studies from National Institute of Allergy and Infectious Diseases Virus-Neutralizing Antibodies in Human Clinical Samples
Studies from National Institute of Allergy and Infectious Diseases Virus-Neutralizing Antibodies in Human Clinical Samples
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Studies from National Institute of Allergy and Infectious Diseases Virus-Neutralizing Antibodies in Human Clinical Samples

Hematology Week, 2021, p.1197

NewsRX LLC

Texto completo disponível

Citações Citado por
6
New Ebola Virus Study Findings Recently Were Reported by Researchers at OyaGeneral Inc
New Ebola Virus Study Findings Recently Were Reported by Researchers at OyaGeneral Inc
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

New Ebola Virus Study Findings Recently Were Reported by Researchers at OyaGeneral Inc

Malaria Weekly (Atlanta, GA), 2021, p.26

NewsRX LLC

Texto completo disponível

Citações Citado por
7
RNA Viruses - Lymphocytic Choriomeningitis Virus; New Lymphocytic Choriomeningitis Virus Study Findings Recently Were Published by Researchers at Scripps Research Institute (Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against ...)
RNA Viruses - Lymphocytic Choriomeningitis Virus; New Lymphocytic Choriomeningitis Virus Study Findings Recently Were Published by Researchers at Scripps Research Institute (Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against ...)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

RNA Viruses - Lymphocytic Choriomeningitis Virus; New Lymphocytic Choriomeningitis Virus Study Findings Recently Were Published by Researchers at Scripps Research Institute (Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against ...)

Drug Week, 2020, p.3499

Atlanta: NewsRx

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.